More importantly, both VEGF and VEGFR-2 are notably higher at the sites of bone metastasis than at the primary prostate tumors of the same individual, further demonstrating the importance of the VEGF/VEGFR-2 axis in prostate cancer bone metastasis [117]. Here, KDR is linked to prostate carcinoma.